Tilray Brands (TLRY) EPS (Basic) (QoQ) (2017 - 2026)
Tilray Brands (TLRY) EPS (Basic) (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Tilray Brands | 513.20 Mn | 278.57 Mn | 90.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -18.34% |
| Feb 28, 2026 | 43.21% |
| Nov 30, 2025 | -2,863.19% |
| Aug 31, 2025 | 100.14% |
| May 31, 2025 | -16.38% |
| Feb 28, 2025 | -786.13% |
| Nov 30, 2024 | -149.07% |
| Aug 31, 2024 | -414.93% |
| May 31, 2024 | 109.03% |
| Feb 29, 2024 | -120.19% |
| Nov 30, 2023 | 21.81% |
| Aug 31, 2023 | -128.13% |
| May 31, 2023 | 114.79% |
| Feb 28, 2023 | -1,297.03% |
| Nov 30, 2022 | -21.59% |
| Aug 31, 2022 | 85.20% |
| May 31, 2022 | -815.08% |
| Feb 28, 2022 | 757.84% |
| Nov 30, 2021 | 116.36% |
| Aug 31, 2021 | -107.72% |